Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

SB 913

Next Previous
X
Search
Drug Profile

SB 913

Alternative Names: SB-913

Latest Information Update: 30 Mar 2022

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Sangamo Therapeutics
  • Class Gene therapies; Zinc finger DNA binding proteins
  • Mechanism of Action Gene transference; Iduronate sulfatase replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Mucopolysaccharidosis II
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Mucopolysaccharidosis II

Most Recent Events

  • 22 Feb 2022 Discontinued - Phase-I/II for Mucopolysaccharidosis II in United Kingdom (IV), in January 2021
  • 22 Feb 2022 Discontinued - Phase-I/II for Mucopolysaccharidosis II in USA (IV), in January 2021
  • 07 May 2021 Sangamo Therapeutics terminated the CHAMPIONS phase I/II trial in Mucopolysaccharidosis II in USA and United Kingdom (IV) (NCT03041324) (EudraCT2018-000192-33)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top